TY  - BOOK
AU  - Xin,Z.
AU  - Kupczyk,E.
AU  - Schmitt-Kopplin,P.
AU  - Mueller,C.
TI  - Current and future approaches for in vitro hit discovery in diabetes mellitus
KW  - CELL PAINTING
KW  - HIGH-CONTENT SCREENING
KW  - FUNCTIONAL METABOLOMICS
KW  - LIPIDOMICS
KW  - BIOACTIVES
KW  - DRUG DISCOVERY
N2  - Type 2 diabetes mellitus (T2DM)is a serious public health problem. In this review, we discuss current and promising future drugs, targets, in vitro assays and emerging omics technologies in T2DM. Importantly, we open the perspective to image-based high-content screening (HCS), with the focus of combining it with metabolomics or lipidomics. HCS has become a strong technology in phenotypic screens because it allows comprehensive screening for the cell-modulatory activity of small molecules. Metabolomics and lipidomics screen for perturbations at the molecular level. The combination of these data-intensive comprehensive technologies is enabled by the rapid development of artificial intelligence. It promises a deep cellular and molecular phenotyping directly linked to chemical information about the applied drug candidates or complex mixtures
UR  - https://drive.google.com/file/d/1DvQKgenv40Me4xvpxT3xzZv8PAlFpeUu/view?usp=drivesdk
ER  -